HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laura Astolfi Selected Research

Laura Astolfi Research Topics

Disease

8Neoplasms (Cancer)
06/2023 - 08/2007
6Hearing Loss (Hearing Impairment)
01/2020 - 10/2013
4Ototoxicity
11/2022 - 01/2016
4Deafness (Deaf Mutism)
01/2022 - 09/2012
4Inflammation (Inflammations)
01/2020 - 02/2014
2Squamous Cell Carcinoma of Head and Neck
06/2023 - 03/2019
2Liver Neoplasms (Liver Cancer)
12/2022 - 09/2022
2Necrosis
08/2021 - 01/2019
2Wounds and Injuries (Trauma)
01/2020 - 02/2014
2Sensorineural Hearing Loss
12/2019 - 10/2013
2Stroke (Strokes)
01/2018 - 05/2015
1Hepatocellular Carcinoma (Hepatoma)
09/2022
1Labyrinth Diseases
02/2022
1Tachypnea
01/2022
1COVID-19
01/2022
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2021
1Nasal Polyps (Nasal Polyp)
07/2020
1Ageusia (Hypogeusia)
07/2020
1Rhinosinusitis
07/2020
1Anosmia
07/2020
1Nasal Obstruction
07/2020
1Neoplasm Metastasis (Metastasis)
03/2019
1Carcinoma (Carcinomatosis)
03/2019
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2018
1Body Weight (Weight, Body)
01/2016
1Fibrosis (Cirrhosis)
02/2014
1Mixed Conductive-Sensorineural Hearing Loss
09/2012
1Noise-Induced Hearing Loss (Acoustic Trauma)
01/2012

Drug/Important Bio-Agent (IBA)

6Cisplatin (Platino)FDA LinkGeneric
11/2022 - 08/2007
3AntioxidantsIBA
02/2022 - 01/2016
3coenzyme Q10 (CoQ10)IBA
01/2017 - 01/2012
2Biomarkers (Surrogate Marker)IBA
03/2023 - 01/2020
2palbociclibIBA
12/2022 - 09/2022
2Dexamethasone (Maxidex)FDA LinkGeneric
11/2022 - 01/2020
2SolutionsIBA
07/2020 - 01/2012
1Angiogenesis InhibitorsIBA
06/2023
1Indicators and Reagents (Reagents)IBA
06/2023
1neodymium pyrocatechin disulfonate (NPD)IBA
11/2022
1lithium niobate (LiNbO3)IBA
02/2022
1barium titanate(IV)IBA
02/2022
1AntibodiesIBA
01/2022
1Oxygen (Dioxygen)IBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1Antidepressive Agents (Antidepressants)IBA
01/2021
1Saline SolutionIBA
07/2020
1Hyaluronic Acid (Hyaluronan)IBA
07/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1SERPIN-B5 (maspin)IBA
03/2019
1SiliconesIBA
01/2019
1KanamycinFDA Link
01/2018
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2016
1UbiquinoneIBA
01/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016
12- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
05/2015
1AminoglycosidesIBA
10/2013
1Mitochondrial DNA (mtDNA)IBA
10/2013
112S ribosomal RNAIBA
10/2013
1DNA (Deoxyribonucleic Acid)IBA
09/2012

Therapy/Procedure

2Therapeutics
11/2022 - 01/2022
2Cochlear Implants (Cochlear Implant)
01/2020 - 01/2019
2Electrodes (Electrode)
01/2020 - 01/2019
1Radiotherapy
11/2022
1Intranasal Administration
07/2020
1Investigational Therapies (Experimental Therapy)
12/2019
1Transcranial Magnetic Stimulation
01/2018
1Hearing Aids (Hearing Aid)
01/2017
1Drug Therapy (Chemotherapy)
01/2016
1Brain-Computer Interfaces
05/2015
1Cochlear Implantation
02/2014